HOLX News and Press, Hologic Inc. From 01/24/20

So far, stock market tailwinds because of end of year bonuses, retirement plan contributions, and institutional re-positioning have offset data suggesting the market is overbought. However, a 3% to 5% correction is getting more likely as the rally broadens out (excluding energy), suggesting in...

Hologic, Inc. (Nasdaq: HOLX) announced today the release of the Company’s first sustainability report, Making a Unique Difference in the World . In the report, the Company highlights its global corporate citizenship efforts around the key environmental, social and governance areas t...

The following slide deck was published by Hologic, Inc. in conjunction with this Read more ...

On a preliminary basis , Hologic (NASDAQ: HOLX ) expects FQ1 revenues of ~$850.5M (+2%). Breast health and Diagnostics should account for $331.1M (+2%) and $311.5M (+5%), respectively. More news on: Hologic, Inc., Healthcare stocks news, Earnings news and commentary, Read more ...

-- Revenue of $850.5 Million Grows 2.4%, 2.8% in Constant Currency -- -- Excluding Acquisitions and Divestitures, Revenue Increases 4.1%, 4.6% in Constant Currency -- -- Board of Directors Approves New $500 Million Share Repurchase Plan -- Hologic, Inc. (Nasdaq: HOLX) announced tod...

It was more of the same in the stock market last week in terms of returns, but the catalysts supporting the rally shifted from easing trade tensions and dovish Federal Reserve policy to a deescalating of tensions between the U.S. and Iran. Specifically, a tepid Iranian response to the U.S. str...

Agilent (NYSE: A ) initiated with Overweight rating and $100 (18% upside) price target at Wells Fargo. More news on: Agilent Technologies, Inc., Avantor, Inc., Axonics Modulation Technologies, Inc., Healthcare stocks news, Stocks on the move, , Read more ...

Hologic, Inc. (Nasdaq: HOLX) announced today that the Company plans to release its financial results for the first quarter of fiscal 2020 on Wednesday, January 29, after the market closes. In conjunction with the release, management will host a conference call that day at 4:30 p.m. Eastern T...

10x Genomics (NASDAQ: TXG ) initiated with Buy rating and $100 (32% upside) price target at Citigroup. More news on: 10x Genomics, Inc., AbbVie Inc., AdaptHealth Corp., Healthcare stocks news, Stocks on the move, , Read more ...

Baxter International (NYSE: BAX ) upgraded to Outperform with a $94 (12% upside) price target at Evercore ISI. Shares up  1%  premarket. More news on: Baxter International Inc., Henry Schein, Inc., Medtronic plc, Healthcare stocks news, Stocks on the move, , Read more ...